HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 193 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $61,465 | -87.6% | 40,705 | -79.4% | 0.00% | -100.0% |
| Q4 2022 | $494,793 | +187.7% | 197,917 | +386.2% | 0.00% | – |
| Q3 2022 | $172,000 | +50.9% | 40,705 | 0.0% | 0.00% | – |
| Q2 2022 | $114,000 | -51.1% | 40,705 | +0.0% | 0.00% | – |
| Q1 2022 | $233,000 | -37.4% | 40,695 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $372,000 | -12.7% | 40,695 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $426,000 | -31.2% | 39,888 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $619,000 | +3.0% | 39,888 | +7.7% | 0.00% | 0.0% |
| Q1 2021 | $601,000 | -23.3% | 37,053 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $784,000 | +42.8% | 37,053 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $549,000 | +0.7% | 37,053 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $545,000 | +25.3% | 37,053 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $435,000 | -50.1% | 37,053 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $871,000 | +29.2% | 37,053 | +1.7% | 0.00% | 0.0% |
| Q3 2019 | $674,000 | -0.4% | 36,433 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $677,000 | -16.7% | 36,433 | +9.5% | 0.00% | 0.0% |
| Q1 2019 | $813,000 | -4.9% | 33,283 | +1.0% | 0.00% | -33.3% |
| Q4 2018 | $855,000 | -7.6% | 32,963 | +12.8% | 0.00% | +50.0% |
| Q3 2018 | $925,000 | -6.2% | 29,214 | +15.1% | 0.00% | -33.3% |
| Q2 2018 | $986,000 | +87.8% | 25,380 | +33.5% | 0.00% | +200.0% |
| Q1 2018 | $525,000 | +71.6% | 19,010 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $306,000 | +12.1% | 16,879 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $273,000 | +16.7% | 16,879 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $234,000 | -7.5% | 16,879 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $253,000 | +14.5% | 16,879 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $221,000 | -24.1% | 16,879 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $291,000 | -3.6% | 16,879 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $302,000 | +2.7% | 16,739 | +8.3% | 0.00% | 0.0% |
| Q1 2016 | $294,000 | -23.4% | 15,456 | +7.6% | 0.00% | 0.0% |
| Q4 2015 | $384,000 | +36.2% | 14,366 | +24.3% | 0.00% | 0.0% |
| Q3 2015 | $282,000 | -8.4% | 11,560 | +17.1% | 0.00% | 0.0% |
| Q2 2015 | $308,000 | – | 9,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |